Biogenic Zinc Oxide Nanoparticles and Their Biomedical Applications: A Review
- PMID: 37359387
- PMCID: PMC10118236
- DOI: 10.1007/s10904-023-02550-x
Biogenic Zinc Oxide Nanoparticles and Their Biomedical Applications: A Review
Abstract
Nanotechnology has inscribed novel perception into the material science and one of the most extensively used nanomaterials is Zinc oxide nanoparticles (ZnO NPs) with healthcare and biomedical applications. Because of its outstanding biocompatibility, low toxicity, and low cost, ZnO NPs have become one of the most prominent metal oxide NPs in biological applications. This review highlights the different aspects of ZnO NPs, like their green synthesis as a substitute of conventional route due to avoidance of threat of hazardous, costly precursors and subsequent mostly therapeutic applications. Due to their wide bandwidth and high excitation binding energy, ZnO NPs have undergone extensive research. In addition to their potential applications as antibiotics, antioxidants, anti-diabetics, and cytotoxic agents, ZnO NPs also hold a promising future as an antiviral treatment for SARS-CoV-2. Zn has antiviral properties and may be effective against a variety of respiratory virus species, particularly SARS-CoV-2. This review includes a variety of topics, including the virus's structural properties, an overview of infection mechanism, and current COVID-19 treatments. Nanotechnology-based techniques for the prevention, diagnosis, and treatment of COVID-19 are also discussed in this review.
Keywords: Bio-medical applications; Biogenic synthesis; Nanotechnology; SARS-CoV-2; ZnO NPs.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
Figures





References
-
- E. Z. Gomaa, J. Inorg. Organomet. Polym. Mater. 1–19 (2022).
-
- Mohamed HEA, Afridi S, Khalil AT, Zia D, Shinwari ZK, Dhlamini MS, Maaza M. J. Inorg. Organomet. Polym. Mater. 2020;8:3241–3254. doi: 10.1007/s10904-020-01490-0. - DOI
-
- Ijaz M, Zafar M, Islam A, Afsheen S, Iqbal T. J. Inorg. Organomet. Polym. Mater. 2020;8:2815–2826. doi: 10.1007/s10904-020-01603-9. - DOI
-
- Gujel AA, Bandeira M, Menti C, Perondi D, Guegan R, Roesch-Ely M, Giovanela M, Crespo JS. Polym. Eng. Sci. 2017;58:1800–1809. doi: 10.1002/pen.24781. - DOI
-
- Ahmoum H, Boughrara M, Suait MS, Chopra S, Kerouad M. Phys. B Condens. 2019;560:28–36. doi: 10.1016/j.physb.2019.02.011. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous